Fitxa persona

RUBEN DARIO ARTERO ALLEPUZ
PDI-Catedratic/a d'Universitat

ruben.artero@uv.es
http://www.uv.es/artero

Àrea de coneixement: GENÈTICA
Departament: Genètica

(9635) 43028

Biografia

[Biografia, versió en valencià]

Publicacions en revistes

Activitats anteriors

Estades a Centres de Recerca

Participacions a Congressos

Natalia Riedel; Dulce Peris-Moreno; Jorge Espinosa; Ariadna Bargiela Schönbrunn; Manuel Pérez Alonso; Rubén Artero (2025). Targeting Musashi-2 with antisense oligonucleotides: a therapeutic approach to mitigate muscle pathology in Myotonic Dystrophy type 1. (Comunicació). Synergistic Meeting on Oligonucleotide Therapeutics (SMOT4) . ESPANYA
Rubén Artero (2025). ENTRY-DM: Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy. (Comunicació). Synergistic Meeting on Oligonucleotide Therapeutics (SMOT4) . ESPANYA
Diego Piqueras-Losilla; Judith Walker; Andrea García-Rey; Argimiro Mayoral-Olmos; Ana Díaz-Maqueda; Nuria Barquero; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros. (2025). Fatty Acid Mediated Oligonucleotide Uptake System (FAMOUS) enables antimiR-23b mediated functional and molecular rescue of cognitive dysfunction in DMSXL mice. (Poster). 2025 Myotonic Dystrophy Foundation (MDF) Conference . Indianapolis . ESTATS UNITS D'AMÈRICA
Andrea García-Rey; Diego Piqueras-Losilla; Argimiro Mayoral-Olmos; Ana Díaz-Maqueda; Nuria Barquero; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros. (2025). New insights into DM1 mechanism of pathogenesis: DMPK, MBNL and miR-23b balance as the master key of DM1 pathology. (Poster). 2025 Myotonic Dystrophy Foundation (MDF) Conference . Indianapolis . ESTATS UNITS D'AMÈRICA
Estefanía Cerro-Herreros; Andrea García-Rey; Mouli Chakraborty; Nuria Barquero; Isabel Campillo; Irene González-Martínez; Argimiro Mayoral-Olmos; Diego Piqueras-Losilla; Isabella Castano; Melanie Nufer; Rubén Artero; Beatriz Llamusi. (2025). Fatty Acid Mediated Uptake System (FAMOUS) enables improved oligo delivery to muscle and brain. (Poster). 2025 Myotonic Dystrophy Foundation (MDF) Conference . Indianapolis . ESTATS UNITS D'AMÈRICA
Ariadna Bargiela; Rubén Artero (2024). Promoting meaningful learning through the acquisition of competencies by using an electronic laboratory notebook. (Comunicació). 6th International 'ARTEMİS' Congress on Health and Sports Sciences . Izmir . TURQUIA
Maria Sabater-Arcís; Nerea Moreno; Ariadna Bargiela; David Seoane-Miraz; Mathew Wood; Miguel Varela; Jorge Espinosa-Espinosa; Ruben Artero; Manuel Pérez-Alonso (2024). Mutant DMPK transcripts interacts with miR-107 triggering the MSI2>mir-7>autophagy axis in myotonic dystrophy. (Comunicació). IDMC-14 . Nijmegen . PAÏSOS BAIXOS
Alicia Novella; Javier Poyatos; Ariadna Bargiela; Rubén Artero (2024). Gapmer technology as a therapeutic approach for LGMDD2. (Comunicació). 10th International ARTEMIS Scientific Research Congress ISBN: 978-9952-8541-1-4 . Bucarest . ROMANIA
Natalia Riedel; Dulce Peris; Rubén Artero; Manuel Pérez Alonso; Ariadna Bargiela Schönbrunn (2024). Development of gapmers targeting MSI2: a novel therapeutic target for muscle atrophy in Myotonic Dystrophy type 1. (Comunicació). 10th International ARTEMIS Scientific Research Congress ISBN: 978-9952-8541-1-4 . Bucarest . ROMANIA
Paola Yánez; Natalia Galindo; María Sabater; Ariadna Bargiela; Rubén Artero (2024). Exploring the dynamics of MSI2 expression in LGMDD2: influence of cell differentiation and seeding. (Comunicació). 10th International ARTEMIS Scientific Research Congress ISBN: 978-9952-8541-1-4 . Bucarest . ROMANIA
Paola Dalgo Aguilar; Rubén Artero; Ariadna Bargiela (2024). In vitro evaluation of TNPO3 gene expression levels in Limb-Girdle Muscular Dystrophy D2 (LGMDD2) cells. (Comunicació). 10th International ARTEMIS Scientific Research Congress ISBN: 978-9952-8541-1-4 . Bucarest . ROMANIA
Natalia Galindo; Paola Yánez; María Sabater; Ariadna Bargiela; Ruben Artero (2024). MSI2 as an example of cell differentiation and seeding effects on cell-cycle-regulated genes. (Comunicació). 9th International ACHARAKA Congress on Medicine, Nursing, Midwifery, and Health Sciences . Izmir . TURQUIA
Paola Yánez; Natalia Galindo; María Sabater; Ariadna Bargiela; Rubén Artero (2024). MSI2 expression in LGMDD2: effects of differentiation and cell seeding density. (Comunicació). 9th International Azerbaijan Congress on Life, Engineering, Mathematical, and Applied Sciences ISBN 978-9952-8541-4-5 . AZERBAITJAN
Javier Poyatos-García; Alicia Novella; Marta casado; Carme Cucarella; Juan J Vilchez; Ariadna Bargiela; Rubén Artero (2024). Caracterización y retos de un modelo murino de LGMDD2. (Poster). XVII Reunión Anual del CIBERER 2024 . El Escorial . ESPANYA
I González-Martínez; E Cerro-Herreros; N Moreno-Cervera; Marieke Willemse; Sarah Overby; Walther J.A.A. van den Broek; Derick G. Wansink; B Llamusí; R Artero (2024). Novel antagomiRs that upregulate MBNL1 as candidate therapies for Myotonic dystrophy. (Poster). IDMC-14 . PAÏSOS BAIXOS
G. Menduti; C. Januel; C. Ruatti; N. Berenger-Currias; P. Konieczny; R. Artero; C. Martinat; M. Boido (2024). Exploiting the drug repositioning strategy for the treatment of Spinal Muscular Atrophy: in vitro and in vivo results of a new effective SMN-dependent molecule. (Poster). 4th Scientific International Congress on Spinal Muscular Atrophy . Ghent . BÈLGICA
Rubén Artero; Arturo López-Castel; Raquel Pérez-Gómez; Monica Suelves; Gisela Nogales; Andrea López-Martínez: Virginia Arechavala-Gomeza; Juan M Fernández-Costa; Javier Ramón; Inmaculada Azorín; Nuria Muelas; Carme Fàbrega; Ramón Eritja; Sonia Alonso-Martín; Adolfo López de Munain (2024). RED-DM, the Spanish National Network on Myotonic Dystrophy. (Poster). The 14th International Myotonic Dystrophy Consortium Meeting (IDMC-14) . PAÏSOS BAIXOS
Raquel Perez-Gomez; Irene González-Martínez; Giovanna Menduti; Noemie Berenguer-Currias; Cécile Martinat; Marina Boido; Rubén Artero (2024). Characterization of GT5-Induced Transcriptome Changes in Skeletal Muscles and Spinal Cord of an SMA Mouse Model. (Poster). Motor neuron diseases: understanding the pathogenetic mechanisms to develop therapies - III edition . Turin . ITÀLIA
Rubén Artero (2024). Investigación traslacional en miopatías y síndromes neurológicos raros. (Ponència). XVII Reunión Anual CIBERER 2024 . El Escorial . ESPANYA
María Sabater Arcis; Dulce Peris Moreno; Ariadna Bargiela; Rubén Artero (2024). Boron-containing compounds partially rescue Myotonic Dystrophy type 1 (DM1) molecular signature and phenotype. (Ponència). 6th International 'ARTEMIS' Congress on Health and Sports Sciences DOI:10.13140/RG.2.2.33024.40965 . Izmir . TURQUIA
Paola Dalgo AGUILAR; Rubén ARTERO; Ariadna BARGIELA (2023). Intervention in TNPO3 gene expression in Limb-Girdle Muscular Dystrophy D2 (LGMDD2). (Comunicació). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURQUIA
Andrea García-Rey; Estefanía Cerro-Herreros; Mouli Chakraborty; Nuria Baquero; Isabel Campillo; Irene González-Martínez; Diego Piqueras-Losilla; Isabella Castano; Melanie Nufer; Rubén Artero; Beatriz Llamusí (2023). Lipophilic conjugation ameliorates antimiR PK/PD properties. (Comunicació). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . ESPANYA
Alicia Novella ESTELLÉS; Águeda Blázquez BERNAL; Carme CUCARELLA; Marta CASADO; Ariadna BARGIELA; Rubén ARTERO (2023). Pilot characterization of a LGMDD2 mouse model. (Comunicació). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURQUIA
Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2023). "Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1". (Poster). Final Meeting COST DARTER Bilbao 2023 . ESPANYA
Maria Sabater-Arcís; Nerea Moreno; Ariadna Bargiela; Rubén Artero (2023). Musashi-2 overexpression enhances atrophy phenotypes in vivo by miR-7 repression. (Poster). DARTER COST Action CA17103 Final Meeting - Bilbao . Bilbao . ESPANYA
Diego Piqueras-Losilla; Isabel Campillo; Laura Perea-Galera; Sandra López-Domènech; Beatriz Ballester Llobell; Milagros Rocha-Barajas; Maria Jose Roig-Revert; Ester Fernandez-López; Cristina Peris-Martinez; Clara Barbera-Fuset; Aline Huguet-Lachon; Geneviève Gourdon; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros (2023). Advancing in vivo modeling and delivery systems for triplet repeat expansion-mediated corneal endothelial dystrophy: Implications in AntimiR therapy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . ESPANYA
Isabella Castano; Argimiro Mayoral; Isabel Campillo; Diego Piqueras-Losilla; Nuria Barquero; Andrea García-Rey; Melanie Nufer; Lara Milián; Manuel Mata; María Sancho-Tello; Mauro Llop; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros (2023). Effect of K2210 on a knee osteoarthritis rat model. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . ESPANYA
Beatriz Llamusí; Diego Piqueras Losilla; Isabel Campillo; Andrea Garcia Rey; Melanie Nufer; Nuria Barquero; Aline Huguet; Geneviève Gourdon; Ruben Artero; Estefanía Cerro Herreros (2023). Systemic treatment with a lipophilic conjugated antimiR 23b rescues functional and molecular phenotypes of DM1 cognitive dysfunction in DMSXL mice. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . ESPANYA
Estefanía Cerro-Herreros; Andrea García-Rey; Irene González-Martínez; Mouli Chakraborty; Nuria Barquero Barquero; Diego Piqueras; Isabella Castano; Melanie Nufer; Isabel Campillo; Anna Colom-Rodrigo; Marc Carrascosa-Sàez; Nerea Moreno-Cervera; Beatriz Llamusi; Rubén Artero (2023). Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . ESPANYA
Natalia Riedel, Ariadna Bargiela Schönbrunn, Maria Sabater-Arcís, Jorge Espinosa, Rubén Artero, Manuel Pérez Alonso (2023). Preclinical development of gapmers against a new therapeutic target in Myotonic Dystrophy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . ESPANYA
Giovanna Menduti; Camille Januel; Cristina Ruatti; Noémie Berenger-Currias; Cecile Martinat; Rubén Artero; Piotr Konieczny; Marina Boido. (2023). Uncovering repositioned therapies' efficacy for Spinal Muscular Atrophy treatment. (Ponència). 20th National Congress of the Italian Society for Neuroscience . Turin . ITÀLIA
Maria Sabater-Arcis;Nerea Moreno; Ariadna Bargiela; Rubén Artero (2023). MUSASHI-2 OVEREXPRESSION ENHANCE MUSCLE DYSFUNCTION IN MYOTONIC DYSTROPHY TYPE 1 BY THE REPRESSION OF MIR-7 BIOGENESIS. (Ponència). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURQUIA
Nerea Moreno; Maria Sabater-Arcís; Ariadna Bargiela; Rubén Artero (2023). OLEIC ACID TREATMENT IN MYOTONIC DYSTROPHY TYPE 1 MUSCLE CELLS IMPROVES MUSCLE DYSFUNCTION PHENOTYPES. (Ponència). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURQUIA
Ariadna Bariela Schönbrunn; Manuel Pérez Alonso; Rubén Artero (2022). Fomentar el aprendizaje significativo mediante la adquisición de competencias por medio del uso de un cuaderno de laboratorio electrónico. (Comunicació). Congreso Internacional de Innovación Educativa en Educación Superior . Bilbao . ESPANYA
Andrea García-Rey; Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastes; Marc Carrascosa-Sàez, Irene González-Martínez; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). AntimiR-23b based therapy rescues MBNL1-dependent splicing patterns in a range of Myotonic Dystrophy genetic backgrounds. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . ESPANYA
Anna Colom-Rodrigo; Irene González-Martínez; Arturo López-Castel; Estefanía Cerro-Herreros; Ruben Artero (2022). Involvement of miR-23b and miR-218 in the pathogenesis of Myotonic Dystrophy type 1. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . ESPANYA
Javier Poyatos-Garcia; Águeda Blázquez-Bernal; Marta Selva-Giménez; Ariadna Bargiela; Rafael P. Vázquez-Manrique; Anne Bigot; Ruben Artero; Juan Jesús Vilchez (2022). TNPO3 c.2771delA edition by CRISPR-Cas9 in a muscle cell model of Limb-Girdle Muscular Dystrophy type D2. (Poster). 7th International Myology Congress . Nice . FRANÇA
I González Martínez; E Cerro Herreros; N Moreno Cervera; A García Rey; M Carrascosa Saez; A Arzumanov; D Seoane; M Fischer; Y Jad; R Raz; MA Varela; MJ Wood; B Llamusi; R Artero (2022). Peptide conjugated antimiRs rescue Myotonic Dystrophy phenotypes in animal and cell models by promoting MBNL1 expression. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
M Sabater Arcís; N Moreno; A Bargiela; R Artero (2022). Musashi-2 overexpression contributes to myotonic dystrophy muscle dysfunction by the repression of miR-7 biogenesis. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastesi; Marc Carrascosa-Sàez; Andrea García-Rey; Irene González-Martínez; Kevin Moreno; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). Lead antimiR-23b drug rescues cell phenotypes in a range of Myotonic Dystrophy genetic backgrounds. (Poster). 2022 Myotonic Dystrophy Foundation (MDF) Annual Conference . San Diego . ESTATS UNITS D'AMÈRICA
Nerea Moreno, Maria Sabater-Arcis, Ariadna Bargiela, Ruben Artero (2022). Musashi-2 overexpression enhances atrophy phenotypes in vivo by miR-7 repression. (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference entitled "The perfect tandem: How technology expands the frontiers of biomedicine' . Sevilla . ESPANYA
Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2022). "Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1". (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference . Sevilla . ESPANYA
Marta SELVA-GIMÉNEZ; Javier POYATOS-GARCIA; Águeda BLÁZQUEZ-BERNAL; Ariadna BARGIELA; Jorge ESPINOSA-ESPINOSA; Rafael P. VÁZQUEZ-MANRIQUE; Anne BIGOT; Ruben ARTERO; Juan Jesús VILCHEZ (2022). CRISPR-Cas9 editing of the TNPO3 mutation causing Limb-Girdle Muscular Dystrophy type D2 in a muscle cell model. (Ponència). VIII. International Istambul Scientific Research Congress . Estambul . TURQUIA
Ariadna BARGIELA; Amadeo TEN; Luis Marti BONMATI; Teresa SEVILLA; Ruben ARTERO (2022). In vivo study of muscle dysfunction in myotonic dystrophy mice by quantitative nuclear magnetic resonance imaging. (Ponència). VIII. International Istambul Scientific Research Congress . Estambul . TURQUIA
Agueda Blázquez, Javier Poyatos, Marta Selva, Juan Vílchez, Ruben Artero, Ariadna Bargiela (2022). CRISPR-Cas9 EDITING OF TNPO3 MUTATION IN THE FIRST CELL MODEL OF Limb-Girdle MUSCULAR DYSTROPHY TYPE D2. (Ponència). 5TH INTERNATIONAL CONGRESS ON LIFE, SOCIAL, AND HEALTH SCIENCES IN A CHANGING WORLD . TURQUIA
J Espinosa Espinosa; E. Cerro Herreros; I González Martínez; N Moreno; SJ Overby; B Llamusi; Ruben Artero (2022). Comprehensive transcriptomic characterization of antisense RNA treatments effects on Myotonic dystrophy type 1 cell models. (Ponència). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
Ariadna Bargiela; Amadeo Ten; Luis Martí Bonmatí; Teresa Sevilla; Rubén Artero (2022). Quantitative nuclear magnetic resonance imaging, a tool for in vivo study of muscle dysfunction in myotonic dystrophy model mice. (Ponència). V International New York Academic Research Congress. Online . New York . ESTATS UNITS D'AMÈRICA
Águeda Blázquez-Bernal; Javier Poyatos-Garcia; Marta Selva-Gimenez; Ariadna Bargiela; Juan J. Vilchez; Ruben Artero (2021). Characterization of cell model of LGMDD2 and validation of candidate therapies. (Comunicació). V International LGMD1F-D2 Congress . ESPANYA
Carlos Casillas-Serra; Estela Selma-Soriano; Ruben Artero; Juan Antonio Navarro; Josep Redón (2021). Rabphilin silencing causes dilated cardiomyopathy in a Drosophila´s human model of cardiac-nephrocyte damage. (Poster). Sociedad Española de Genética . ESPANYA
Águeda Blázquez Bernal; Juan M. Fernandez Costa; Ariadna Bargiela; Ruben Artero (2021). Development of a Drosophila model of LGMD1F and drug screening. (Poster). 62nd Annual Drosophila Research Conference . ESTATS UNITS D'AMÈRICA